| 今开：3.26 | 昨收：3.26 |
| 最高：3.345 | 最低：3.1 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.71661379E8 |
Fate Therapeutics(FATE)05-09 21:05
$Fate Therapeutics(FATE)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-24-134840 Act: 34 Size: 192 KB 网页链接查看全文
Fate Therapeutics(FATE)06-01 05:35
$Fate Therapeutics(FATE)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-151963 Act: 34 Size: 141 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071948 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071959 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-11 05:15
$Fate Therapeutics(FATE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-158427 Act: 33 Size: 67 KB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:15
$Fate Therapeutics(FATE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118056 Act: 34 Size: 665 KB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:15
$Fate Therapeutics(FATE)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-117981 Act: 34 Size: 3 MB 网页链接查看全文
Fate Therapeutics(FATE)04-27 04:25
$Fate Therapeutics(FATE)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118086 Act: 34 Size: 11 MB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:45
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071970 Size: 5 KB 网页链接查看全文
Fate Therapeutics(FATE)06-12 04:35
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071950 Size: 5 KB 网页链接查看全文
chuminhua2021-06-05 11:06
$Fate Therapeutics(FATE)$ 6月5日，#ASCO2021# Day1重要演讲：Fate的FT516细胞疗法在早期B细胞淋巴瘤试验中显示73%的缓解率
Fate Therapeutics公司表示，在其通用型的NK细胞疗法FT516与利妥昔单抗联合使用的I期研究中，两个剂量递增队列的11名复发/难治性B细胞淋巴瘤患者中有8人获得了客观反...查看全文
牛唐2021-05-26 10:55
医药板块需要来一个并购，哪些是理想的并购标的呢？
$Horizon Therapeutics(HZNP)$ $TG治疗(TGTX)$ $Fate Therapeutics(FATE)$ ALLK IOVA BIIB ARWR查看全文
Replix锐璞美股2021-04-09 19:31
$Affimed(AFMD)$ 数据不错，盘前涨了一些。
Affimed Announces Presentation at AACR Hi ghlighting Initial Data from Phase 1 St udy of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
All four patients experienced significant disease red...查看全文
月化五白龙2021-01-19 20:33
$Intellia(NTLA)$$Editas Medicine(EDIT)$ $Fate Therapeutics(FATE)$ 基因编辑治本，十年大方向吗查看全文
全球时尚奢品2021-01-11 20:37
寒潮一波接一波，再追求美丽动人的女生也纷纷裹起了羽绒大衣。还在物色羽绒棉衣的朋友，或许可以上 $寺库(SECO)$ 挑一挑。作为亚洲领先的线上线下精品生活方式平台，寺库平台内汇聚了大量来自世界各地的奢侈品品牌。在寺库，除了买大牌还可以挑选小众品牌、设计师品牌，不喜欢与他人撞衫的朋友，上...查看全文
GreenTech绿科技2021-01-10 07:16
$Skillz(SKLZ)$ 和$Fate Therapeutics(FATE)$ 获得了ARK连续5个交易日的加仓。
SKLZ从2021年1月4日开始建仓，连续5个交易日加仓，目前在ARKW的持仓市值为1021万美元。公司具体情况可参考公众号(arkshipan)1月4日文章：网页链接查看全文
奕维科技2021-01-08 12:10
ARKK最近轮动了不少股，昨天新建了$10x Genomics(TXG)$ ，$Fate Therapeutics(FATE)$ ，今天又新建了$诺华制药(NVS)$ ，同时也减仓了好几只查看全文
美港电讯APP2021-01-07 08:56
美港电讯独家 | ARKK方舟创新ETF 1月6日（周三）持仓变动一览：减持NanoString Technologies(NSTG.O) 7.6万股，减持比例3.1%；减持ExOne(XONE.O) 4万股，减持比例7.7%；建仓10x Genomics(TXG.O)；建仓Fate Therapeutics(FATE.O)>>>（美港电讯app）$Fate Therapeutics(FATE)$ $10x Genomic...查看全文
交易追踪 ARK 9月3日共有37笔交易，笔数变化不大，个股成交额有所放大，其中，斥资约4000万美元买入美国流媒体领军者Roku，卖出1900万美元加拿大电商服务平台Shopify。此外，还有买入Fate Therapeutics、卖出Square等标的。ARK基金创始人“... 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070506 Size: 9 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-070507 Size: 7 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071970 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071941 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071945 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071947 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071948 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071950 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071959 Size: 5 KB 网页链接
$Fate Therapeutics(FATE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-158427 Act: 33 Size: 67 KB 网页链接